US researchers decoded actinium, a 125-year-old element, for improved cancer treatments through targeted alpha therapy (TAT).

US researchers from Berkeley Lab decoded actinium, a 125-year-old element, that could improve cancer treatments. Actinium-225, an isotope with promising potential in targeted alpha therapy (TAT), emits energetic particles to kill cancer cells while preserving healthy tissue. Researchers grew crystals containing actinium to study its atomic structure, aiding in the development of better delivery systems for targeted cancer treatments.

July 15, 2024
4 Articles